Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. scores highest on Earnings (53) and lowest on Price (0). Its PosiPenta is 29.78 out of 100, weaker than most similar companies.
On the Penta Grid this week, Ensysce Biosciences, Inc. is Grid #761 of 837 in the Healthcare sector in United States, and Grid #3,626 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. | 29.78 | 0 | 53 | 29 | 27 | 40 |
| Palatin Technologies, Inc. | 31.57 | 39 | 36 | 20 | 33 | 30 |
| Phio Pharmaceuticals Corp. | 43.11 | 42 | 51 | 20 | 57 | 46 |
| IN8bio, Inc. | 43.40 | 44 | 44 | 39 | 38 | 52 |
| Citius Pharmaceuticals, Inc. | 35.76 | 49 | 35 | 16 | 43 | 36 |
| Kiora Pharmaceuticals, Inc. | 47.63 | 44 | 28 | 79 | 57 | 30 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.21 |
| P/B ratio | -12.90 |
EEarnings
| Trailing EPS | ₹-233.95 |
| Forward EPS | ₹-4.74 |
NNitro
| Price | 49.09 |
| 52-week high | 251.94 |
| 52-week low | 21.78 |
| Fall from 52-week high | 80.5% |
TTorque
| Return on equity (ROE) | -1295.09% |
| Debt-to-equity | 0.10 |
AAnchor
| Beta (price swings) | 1.02 |
| Market cap | ₹95 Cr |
| Insider holding | 4.72% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Ensysce Biosciences, Inc.'s PosiPenta score?
Ensysce Biosciences, Inc.'s PosiPenta is 29.78 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Ensysce Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Ensysce Biosciences, Inc. is Grid #761 of 837 in the Healthcare sector in United States, and Grid #3,626 of 4,000 in United States.
Which PosiPenta pillar is strongest for Ensysce Biosciences, Inc.?
Earnings (growth), with a score of 53 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Ensysce Biosciences, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.